Financhill
Back

Lexaria Bioscience Quote, Financials, Valuation and Earnings

Lexaria Bioscience Price Quote

$2.17
-0.03 (-1.36%)
(Updated: November 21, 2024 at 5:55 PM ET)

Lexaria Bioscience Key Stats

Sell
26
Lexaria Bioscience (LEXX) is a Sell

Day range:
$2.16 - $2.28
52-week range:
$1.20 - $6.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
53.11
P/B ratio:
3.26%

Volume:
96.9K
Avg. volume:
133.1K
1-year change:
78.86%
Market cap:
$33M
Revenue:
$226.2K
EPS:
$-0.44

How Much Does Lexaria Bioscience Make?

Is Lexaria Bioscience Growing As A Company?

  • What Is Lexaria Bioscience's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Lexaria Bioscience's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Lexaria Bioscience Stock Price Performance

What Is Lexaria Bioscience 52-Week High & Low?

Lexaria Bioscience Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lexaria Bioscience?

Is Lexaria Bioscience Cash Flow Positive?

  • What Is LEXX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$4.7M
  • What Is Lexaria Bioscience’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.2M
  • What Is Lexaria Bioscience’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$187.5K

Lexaria Bioscience Return On Invested Capital

  • Is Management Doing A Good Job?
    LEXX return on invested capital is -93.31%
  • What Is Lexaria Bioscience Return On Assets?
    ROA measures how assets are converting to revenues and is -85.62%
  • What Is LEXX Return On Equity?
    ROE is a measure of profitability and is -93.31%

Lexaria Bioscience Earnings Date & Stock Price

Lexaria Bioscience Competitors

  • Who Are Lexaria Bioscience's Competitors?
    Below is a list of companies who compete with Lexaria Bioscience or are related in some way:
    • Aurinia Pharmaceuticals Inc (AUPH)
    • Edesa Biotech Inc (EDSA)
    • ESSA Pharma Inc (EPIX)
    • ImmunoPrecise Antibodies Ltd (IPA)
    • Xenon Pharmaceuticals Inc (XENE)

Lexaria Bioscience Dividend Yield

Lexaria Bioscience Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 8.1% -16%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 10.00
Upside from Last Price: 354.55%

Major Shareholders

  • How many LEXX shares are owned by institutional investors?
    2.3M LEXX shares are owned by institutional investors
  • How many LEXX shares are owned by insiders?
    4.3M LEXX shares are owned by insiders